James C. D'Arecca

James C. D'Arecca

Executive Vice President, Chief Financial OfficeratHaemonetics· In proxies 2022–2025

Pay in FY2023

James C. D'Arecca was paid $3.8M in FY2023 (Apr).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Haemonetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. HaemoneticsPublic company · 4 yr
    • Executive Vice President, Chief Financial Officer2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?